ClinicalTrials.gg
Enrolling by invitationNCT04763720Updated Jul 9, 2025

Implementing Dyadic Developmental Psychotherapy (DDP) - Evaluation Research

An observational study in Psychiatric Problem, Child Neglect and Maltreatment, sponsored by Sykehuset Telemark. Enrolling by invitation at 1 site in Norway. Open to participants aged 5 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-07-09.

Sponsored by Sykehuset Telemark · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
5 Years to 99 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the implementation and use of Dyadic Developmental Psychotherapy (DDP) in three centra, with particular focus on its potential effects on the quality of the observable caregiver-child interaction. The three centra included are Telemark Hospital Trust, Department for Child- and Adolescent Psychiatric Health, Child Protective Services in Skien and Child Protective Services in Porsgrunn. The implementation of DDP is being led by Telemark Hospital Trust, while therapists from all centra are being trained in DDP as part of the implementation process.

Primarily we aim to identify any changes associated with DDP treatment in the caregiver-child interaction, as measured by the Emotional Availability Scales (EA scales). Our secondary outcome measures assess changes in parental self-efficacy, parental stress, and child emotional and behavioral problems.

The research aims are divided in three research questions:

Q1: What changes are associated with DDP treatment:

Q1.1 the quality of the caregiver-child interaction Q1.2 parental self-efficacy Q1.3 parental stress, Q1.4 child emotional and behavioral problems Based on previous literature, we hypothesize that we will see an increase in the quality of the caregiver-child interaction and parental self-efficacy after completing the DDP treatment, and a decrease in parental stress and child emotional and behavioral problems (Becker-Weidman, A. 2006)

In addition to assessing the effects of DDP we will evaluate the implementation of DDP in the three centra, and inform the implementation by collecting information through interviews with patients and clinicians. We aim to answer:

Q2: How do children and their caregivers experience DDP as a therapeutic intervention? Q3: How do clinicians experience the training process and the use of DDP as a therapeutic intervention?

Based on previous literature, we hypothesize that we will see an increase in the quality of the caregiver-child interaction and parental self-efficacy after completing the DDP treatment, and a decrease in parental stress and child emotional and behavioral problems

Read the detailed description

Children who have been subject to physical, sexual or emotional abuse or neglect are at risk of developing unhealthy relationships with their caregiver, increasing the likelihood of them developing a wide range of mental health problems later in life. Norway offers few therapeutic programs for treatment of children and adolescents that focus specifically on treating traumatic experiences within attachment relationships. An intervention with this focus is Dyadic Developmental Psychotherapy (DDP),where dyad refers to the unit of a child and its caregiver(s).

The Family-Based Treatment Unit (SFB) within the Division for Child- and Adolescent Mental Health (ABUP) at Telemark Hospital has started implementing DDP with funding from the "BUP Project", resulting in a multi-center implementation plan including local child protective services and the office for children, youth and family affairs. This project seeks to evaluate the implementation of DDP and assess any change in the quality of the caregiver-child interaction, parental efficacy, parental stress and wellbeing, and child emotional and behavioral problems as well as the subjective experience of this implementation among caregivers and clinicians. The results of interviews with clinicians and parents will provide feedback, guide the implementation, and provide essential knowledge about using DDP in a Norwegian setting.

Child protective services (CPS) in the municipalities of Skien and Porsgrunn will be implementing DDP in their respective services and their experiences with the process will also be collected. Mixed method assessment will be used to follow the implementation process.

The present study will contribute new knowledge of how the intervention is experienced by Norwegian children and their families, both in a clinical outpatient setting at Telemark Hospital as well as Skien and Porsgrunn Child Protective Services.

Clinicians' experiences with the implementation and use of DDP is an important dimension for its success.The project will report on what challenges arose during implementation in Norway, and how both families and clinicians experienced the process of learning, using and receiving DDP. By using the information gained directly into the process of this project it can help guide the continued implementation and contribute to its success. If DDP is shown to be a positive and helpful therapeutic methods there are plans for a multi-center randomized controlled trial.

We will investigate the specific context through participant-observations during project meetings, and analyze central documents regarding the implementation and use of DDP.

Through working closely with Child Protective Services we will also be able to explore the experiences of implementation of the treatment in different settings.

Ethical review has been conducted by the Norwegian South East Regional committee for Medical and Health Research (REK) as well as the Norwegian Centre for Research Data (NSD) and the project has been approved. The participants will receive full information, and be asked to give consent both verbally and in writing. They will be assured confidentiality and anonymity. They will be informed of their right to withdraw at any time, and that it will have no impact on their treatment at ABUP. We do not expect this study to cause any harm to participants. The observations are part of routine examination, of short duration and are conducted within the security of a familiar institution

02

Conditions studied

  • Psychiatric Problem
  • Child Neglect
  • Maltreatment
  • Child Behavior Problem
  • DDP

Browse trials for

Keywords

  • Attachment
  • Dyadic Developmental Psychotherapy
  • Trauma
  • Therapy
03

In context

Wounds and Injuries

2,221 studies on the registry are indexed under Wounds and Injuries; 442 are open to participants now.

This study's planned enrollment of 100 is below the median of 169 across 690 observational studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Sykehuset Telemark is the lead sponsor of 33 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Families receiving DDP treatment at any of the centra, that fulfill the eligibility criteria.

Eligibility criteria

Inclusion criteria for child:

  1. Symptoms of relational and/or attachment difficulties
  2. History of trauma, including neglect or emotional abuse
  3. Age 5-18
  4. Can understand and make oneself understood in Norwegian

Exclusion criteria for dyad (caregiver and child):

  1. Current substance abuse in child or caregiver
  2. Current psychosis in child or caregiver
  3. Intellectual disability in caregiver Variables that will be tracked but that are not grounds for exclusion are diagnostic variables, including the presence of autism-spectrum disorders, and care-level.

Inclusion criteria for therapists:

  1. Trained in DDP
  2. Working with DDP in either of the centra
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dyadic Developmental Psychotherapy

    Families being treated with DDP at either of the centres

    Behavioral: Dyadic Developmental Psychotherapy

Interventions

  • BehavioralDyadic Developmental Psychotherapy

    DDP involves approximately twenty sessions with the family, conducted by a trained DDP therapist. DDP is developed to treat trauma-related and attachment difficulties. DDP is not a manualized treatment but involves using a set of core communication techniques (termed PACE; Playfulness, Acceptance, Curiosity and Empathy).

    Also known as: DDP

06

What researchers measure

Primary outcomes

  1. Change in quality of caregiver-child interaction

    The quality of caregiver-child interaction using the "Emotional Availability Scales". Max total score is 29 and a higher score means better quality interaction.

    Time frame: Time 1 is when the family is referred to DDP treatment, time 2 when treatment is finished, approximately 24 weeks later

Secondary outcomes

  1. Change in measured parental self-efficacy

    Measure of change in parental self-efficacy/competency as measured by the "Parenting Sense of Competence" scale. Max score 96, higher score indicates higher perceived competence.

    Time frame: Time 1 is when the family is referred to DDP treatment, time 2 when treatment is finished, approximately 24 weeks later

  2. Change in parental stress

    Measure of change in parental stress as measured by the "Parental Stress Scale". Max score is 90 and a higher score indicates higher parental stress.

    Time frame: Time 1 is when the family is referred to DDP treatment, time 2 when treatment is finished, approximately 24 weeks later

  3. Change in child symptoms of traumatic stress

    Measure of child's symptoms of traumatic stress as measured by "Child and Adolescent Trauma Screening". Max score is 60, higher score indicates higher levels of traumatic stress.

    Time frame: Time 1 is when the family is referred to DDP treatment, time 2 when treatment is finished, approximately 24 weeks later

  4. Change in child emotional and behavioral symptoms

    General screening of child's symptoms of emotional and behavioral problems, as measured by the "ASEBA" (Achenbach System of Empirically Based Assessment) Child Behavior Checklist. ASEBA uses standardized scores according to age-specific norms, where higher t-scores indicates more/stronger symptoms on each subscale.

    Time frame: Time 1 is when the family is referred to DDP treatment, time 2 when treatment is finished, approximately 24 weeks later

Other outcomes

  1. Caregiver's experience of receiving DDP

    Semi-structured interview exploring the caregiver's experience receiving DDP treatment

    Time frame: Approximately 24 weeks after the family has been referred to DDP treatment

  2. Therapists experience of the implementation and use of DDP

    Semi-structured focus-group interviews with DDP therapists exploring their experience with the implementation and use of DDP

    Time frame: Up to every 3rd month after the therapist has been trained in DDP, until the end of the data collection period (31.12.2023)

07

Study locations

1 site
08

References and documents

Publications

  • Becker-Weidman A. Treatment for Children with Reactive Attachment Disorder: Dyadic Developmental Psychotherapy. Child Adolesc Ment Health. 2008 Feb;13(1):52. doi: 10.1111/j.1475-3588.2006.00428.x. No abstract available. PubMed 32847154 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2021 (actual). Primary completion is estimated for Feb 2028, 85 months after the start.

Of 265 non-industry observational studies under Wounds and Injuries, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's planned 85 months is above that.

Counting every sponsor, half of 312 studies reached it within 28 months; a quarter within 12 and three quarters within 60.

Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2021
First posted
Feb 21, 2021
StartActual
Jan 1, 2021
Primary completionEst.
Feb 29, 2028
CompletionEst.
Feb 29, 2028
Last update
Jul 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04763720
Lead sponsor
Sykehuset Telemark
Responsible party
Sponsor
First posted
Feb 21, 2021
Start date
Jan 1, 2021
Primary completion
Feb 29, 2028 (estimated)
Completion
Feb 29, 2028 (estimated)
Last update
Jul 9, 2025

Study contacts

Idun Røseth, Ph.D
principal investigator · Telemark Hospital Trust - University of South-East Norway

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion